NCT05169164

Brief Summary

Methods: International, seven-day observational cohort study of complications following elective or emergency surgery. Objectives: To provide detailed data describing post-operative complications and associated mortality. Number of participants: Our aim is to recruit as many patients from as many hospitals as possible in Latin American nations. Eligible countries for participation: Countries and dependencies in Latin America that are situated in the area stretching from the northern border of Mexico to the southern tip of South America, including the Caribbean. Inclusion criteria: all adult patients aged 18 years or older undergoing elective or emergency surgery during the seven-day study period with a planned overnight stay. Exclusion criteria: patients who are undergoing planned day-case surgery or radiological procedures. Statistical methodology and analysis: Single and multi-level logistic regression models will be constructed to identify factors independently associated with these outcomes and to adjust for differences in confounding factors. A single final analysis is planned at the end of the study. A pre-defined analysis will focus on outcomes of patients who have undergone caesarean section. Study duration: Each nation will select a 7-day period between 1st April and 31th October 2022.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 23, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

August 9, 2023

Status Verified

August 1, 2023

Enrollment Period

12 months

First QC Date

December 8, 2021

Last Update Submit

August 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative complications

    In-hospital postoperative complications of any cause, censored at 30 days following surgery for patients who remain in hospital

    30 days

Secondary Outcomes (3)

  • Mortality

    30 days

  • Hospital stay

    30 days

  • Critical care

    30 days

Study Arms (1)

Single group

All adult patients (aged 18 years or older) undergoing elective or emergency surgery with a planned overnight stay. No interventions, only observational.

Other: No intervention, observational

Interventions

No intervention, observational

Single group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Each national group will select a single seven-day period for patient recruitment between 1st April and 31st October 2022. Patients will be identified by the participating sites by review of elective theatre lists, theatre logbooks, handover sheets, emergency admissions and ward lists. All patients undergoing surgery over this period at a hospital taking part in the study will be eligible for inclusion provided they meet the following criteria.

You may qualify if:

  • All adult patients (aged 18 years or older) undergoing elective or emergency surgery with a planned overnight stay.
  • Surgery is defined as a procedure where a deliberate access to the body is gained via an incision or percutaneous puncture, and where instrumentation is used in addition to the puncture needle, or instrumentation via a natural orifice.

You may not qualify if:

  • Patients who are undergoing planned day-case surgery or radiological procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banco de Prótesis

Montevideo, Uruguay

Location

Related Publications (2)

  • Latin American Surgical Outcomes Study (LASOS) group. Patient outcomes after surgery in 17 Latin American countries (LASOS): a 7 day prospective cohort study. Lancet Glob Health. 2025 Apr;13(4):e635-e645. doi: 10.1016/S2214-109X(24)00558-8.

  • Hajjar LA, Quintao VC, Vieira APZ, Nakada LN, Pearse RM, Ramirez MBD, la Medina AR, Alvarez A, McLoghlin S, Boccalatte L, Padmore G, Feraudy I, Martinez M, Villablanca N, Perez C, Calvache JA, Lincango E, Sosa R, Shu S, Riva J, Godinez L, Frias M, Major D, Licea M, Batista S, Charles S, Vaca M, Rosado ID, Borunda D, Zaky OB, Cardona CMC, Carmona MJC, Stefani LC. Latin American surgical outcomes study: study protocol for a multicentre international observational cohort study of patient outcomes after surgery in Latin American countries. BJA Open. 2022 Aug 19;3:100030. doi: 10.1016/j.bjao.2022.100030. eCollection 2022 Sep.

Related Links

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ludhmila Hajjar, MD, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 8, 2021

First Posted

December 23, 2021

Study Start

April 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

August 9, 2023

Record last verified: 2023-08

Locations